PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Biology, And Graduate School of Biomedical Sciences, School of Osteopathic Medicine, Rowan University, Stratford, NJ, 08084, USA.\', \'National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, MS, 38677, USA.\', \'Department of Physiology and Biophysics, School of Medicine, Stony Brook University Stony Brook, NY, 11794-8661, USA.\', \'Department of Cell Biology and Neuroscience, Cell and Gene Therapy Center, And Graduate School of Biomedical Sciences, School of Osteopathic Medicine, Rowan University, Stratford, NJ, 08084, USA.\', \'Regional Bio-containment Laboratory, Center for COVID-19 Response and Pandemic Preparedness (CRP2), Rutgers-New Jersey Medical School, Newark, NJ, 07103, USA.\', \'Department of Molecular Biology, And Graduate School of Biomedical Sciences, School of Osteopathic Medicine, Rowan University, Stratford, NJ, 08084, USA. Electronic address: gary.goldberg@rowan.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0014-4827(21)00126-910.1016/j.yexcr.2021.112594
?:hasPublicationType
?:journal
  • Experimental cell research
is ?:pmid of
?:pmid
?:pmid
  • 33823179
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.583
?:rankingScore_hIndex
  • 171
is ?:relation_isRelatedTo_publication of
?:title
  • Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all